Skip to main content

Table 3 Quality assessment of comparative non-randomized studies

From: Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP)

Studies

Country

Pre-intervention and at-intervention domains

Post-intervention domains

Overall risk of bias

Bias due to confounding

Bias in selection of participants in the study

Bias in classification of interventions

Bias due to deviations from intended interventions

Bias due to missing data

Bias in measurement of outcomes

Bias in selection of the reported result

Harder 2013 [16]

Germany

M

L

L

L

L

M

L

M

Isaac 2015 [8]

Canada

M

M

L

L

L

M

L

M

Hwang 2015 [9]

USA

M

L

L

L

L

M

L

M

Gunay 2016 [11]

Turkey

M

M

M

L

L

M

L

M

Mueller2016 [7]

Germany

M

M

M

L

L

M

L

M

Walz 2016 [26]

Germany

M

L

L

L

M

L

L

M

  1. L, low risk of bias; M, moderate risk of bias.